Your browser doesn't support javascript.
loading
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Fendler, Annika; Au, Lewis; Shepherd, Scott T C; Byrne, Fiona; Cerrone, Maddalena; Boos, Laura Amanda; Rzeniewicz, Karolina; Gordon, William; Shum, Benjamin; Gerard, Camille L; Ward, Barry; Xie, Wenyi; Schmitt, Andreas M; Joharatnam-Hogan, Nalinie; Cornish, Georgina H; Pule, Martin; Mekkaoui, Leila; Ng, Kevin W; Carlyle, Eleanor; Edmonds, Kim; Rosario, Lyra Del; Sarker, Sarah; Lingard, Karla; Mangwende, Mary; Holt, Lucy; Ahmod, Hamid; Stone, Richard; Gomes, Camila; Flynn, Helen R; Agua-Doce, Ana; Hobson, Philip; Caidan, Simon; Howell, Michael; Wu, Mary; Goldstone, Robert; Crawford, Margaret; Cubitt, Laura; Patel, Harshil; Gavrielides, Mike; Nye, Emma; Snijders, Ambrosius P; MacRae, James I; Nicod, Jerome; Gronthoud, Firza; Shea, Robyn L; Messiou, Christina; Cunningham, David; Chau, Ian; Starling, Naureen; Turner, Nicholas.
Affiliation
  • Fendler A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Shepherd STC; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Byrne F; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Cerrone M; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Boos LA; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Rzeniewicz K; Tuberculosis Laboratory, The Francis Crick Institute, London, UK.
  • Gordon W; Department of Infectious Disease, Imperial College London, London, UK.
  • Shum B; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Gerard CL; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Ward B; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Xie W; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Schmitt AM; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Joharatnam-Hogan N; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Cornish GH; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Pule M; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
  • Mekkaoui L; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Ng KW; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Carlyle E; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Edmonds K; Department of Haematology, University College London Cancer Institute, London, UK.
  • Rosario LD; Autolus Ltd., London, UK.
  • Sarker S; Autolus Ltd., London, UK.
  • Lingard K; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.
  • Mangwende M; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Holt L; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Ahmod H; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Stone R; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Gomes C; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Flynn HR; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Agua-Doce A; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Hobson P; Skin and Renal Units, The Royal Marsden NHS Foundation Trust, London, UK.
  • Caidan S; Experimental Histopathology Laboratory, The Francis Crick Institute, London, UK.
  • Howell M; Experimental Histopathology Laboratory, The Francis Crick Institute, London, UK.
  • Wu M; Mass Spectrometry Proteomics Science Technology Platform, The Francis Crick Institute, London, UK.
  • Goldstone R; Flow Cytometry Scientific Technology Platform, The Francis Crick Institute, London, UK.
  • Crawford M; Flow Cytometry Scientific Technology Platform, The Francis Crick Institute, London, UK.
  • Cubitt L; Safety, Health and Sustainability, The Francis Crick Institute, London, UK.
  • Patel H; High Throughput Screening Laboratory, The Francis Crick Institute, London, UK.
  • Gavrielides M; High Throughput Screening Laboratory, The Francis Crick Institute, London, UK.
  • Nye E; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Snijders AP; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • MacRae JI; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Nicod J; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
  • Gronthoud F; Scientific Computing Scientific Technology Platform, The Francis Crick Institute, London, UK.
  • Shea RL; Experimental Histopathology Laboratory, The Francis Crick Institute, London, UK.
  • Messiou C; Mass Spectrometry Proteomics Science Technology Platform, The Francis Crick Institute, London, UK.
  • Cunningham D; Metabolomics Scientific Technology Platform, The Francis Crick Institute, London, UK.
  • Chau I; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.
  • Starling N; Department of Pathology, The Royal Marsden NHS Foundation Trust, London, UK.
  • Turner N; Department of Pathology, The Royal Marsden NHS Foundation Trust, London, UK.
Nat Cancer ; 2(12): 1321-1337, 2021 12.
Article de En | MEDLINE | ID: mdl-35121900
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Anticorps neutralisants / COVID-19 / Anticorps antiviraux / Tumeurs Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Nat Cancer Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T / Anticorps neutralisants / COVID-19 / Anticorps antiviraux / Tumeurs Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Nat Cancer Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni